Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities

scientific article published on 06 February 2020

Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1037/PHA0000350
P932PMC publication ID7415473
P698PubMed publication ID32027158

P50authorAndrea C. VillantiQ48248015
Jennifer TideyQ60055546
Cecilia L BergeriaQ89571914
John R HughesQ89571916
P2093author name stringStacey C Sigmon
Sarah H Heil
Maxine L Stitzer
Stephen T Higgins
Diann E Gaalema
Danielle R Davis
Jeffrey Priest
Joanna M Streck
P2860cites workAre Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future DirectionsQ26801047
Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disordersQ33716576
Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette DependenceQ34029147
Smoking and mental illness in the U.S. populationQ34362758
Randomized Trial of Reduced-Nicotine Standards for Cigarettes.Q34496332
Intolerance for withdrawal discomfort and motivation predict voucher-based smoking treatment outcomes for smokers with substance use disordersQ35007655
Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patientsQ35024272
Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.Q36047601
Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective reviewQ36762000
Cigarette smoking, socioeconomic status, and psychosocial factors: examining a conceptual frameworkQ36841943
Reduced nicotine content cigarettes and nicotine patchQ36927046
Measurement of socioeconomic status in health disparities research.Q36959114
An international systematic review of smoking prevalence in addiction treatmentQ37187104
Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smokingQ37206730
Socioeconomic status and smoking: a reviewQ37957179
Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder.Q38385795
Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco AddictionQ38612443
Current Cigarette Smoking Among Adults - United States, 2005-2015.Q39198854
Smoking and mental illness: A population-based prevalence studyQ39513259
Predictors of nicotine withdrawal symptoms: findings from the first randomized smoking cessation trial in a low-income country settingQ39847521
Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004-2013.Q40437665
Errors in using tobacco withdrawal scaleQ42746927
Interest in smoking cessation among injection drug usersQ43667218
Current cigarette smoking among adults - United States, 2005-2012.Q45386693
Methadone-nicotine interactions in methadone maintenance treatment patients.Q46013631
Establishing a nicotine threshold for addiction. The implications for tobacco regulationQ46058830
Development and validation of an Overall Anxiety Severity And Impairment Scale (OASIS).Q46100865
Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigaretteQ46897472
Signs and symptoms of tobacco withdrawalQ49016637
Tobacco Withdrawal Among Opioid-Dependent SmokersQ49495854
The early time course of smoking withdrawal effects.Q50935985
Cigarette smoking and subjective response: Effects of d-amphetamineQ52271040
A Nicotine-Focused Framework for Public Health.Q53553970
Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adultsQ53847483
Treating Cigarette Smoking in Methadone Maintenance ClientsQ67815481
Buprenorphine effects on cigarette smokingQ69962071
Effects of methadone on human cigarette smoking and subjective ratingsQ71362184
Interim buprenorphine treatment during delays to comprehensive treatment: Changes in psychiatric symptomsQ89231006
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid EnrolleesQ91057652
Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacementQ92349081
P921main subjectopioid use disorderQ1639178
substance use disorderQ7632070
P577publication date2020-02-06
P1433published inExperimental and Clinical PsychopharmacologyQ15716319
P1476titleInvestigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities

Search more.